Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GLAXF) Shares Outstanding (Weighted Average) (2017 - 2023)

Historic Shares Outstanding (Weighted Average) for Gsk (GLAXF) over the last 9 years, with Q1 2023 value amounting to $4915521.0 billion.

  • Gsk's Shares Outstanding (Weighted Average) changed N/A to $4915521.0 billion in Q1 2023 from the same period last year, while for Mar 2023 it was $4915521.0 billion, marking a year-over-year change of. This contributed to the annual value of $6294315.6 billion for FY2017, which is N/A changed from last year.
  • Gsk's Shares Outstanding (Weighted Average) amounted to $4915521.0 billion in Q1 2023.
  • Gsk's Shares Outstanding (Weighted Average)'s 5-year high stood at $4915521.0 billion during Q1 2023, with a 5-year trough of $4915521.0 billion in Q1 2023.